Google, one of the world's leading technology companies, recognizes the power of AI in revolutionizing clinical research.
Using AI algorithms, large amounts of genomic data, clinical trials, and scientific paperrs, can be effectively analyzed. This analysis facilitates the identification of potential targets for drug development and disease biomarkers, opening avenues for significant advancements in disease treatment and prevention in both animals and humans!
Recent breakthroughs in veterinary medicine, such as the development of monoclonal antibody therapy for treating canine atopic dermatitis and monoclonal antibody treatment for canine parvovirus, exemplify the remarkable potential for innovation in new drug development.
Advancement in the medical and veterinary field requires the collaboration of diverse professionals from various disciplines, such as researchers, clinicians, data scientists, bioinformaticians, and experts from related fields. By working together, we have the potential to create groundbreaking solutions.
About the author
Dr. Aline Santana is a Brazilian veterinarian with over 12 years of experience in both research and private dermatology practice. In 2021, she completed her PhD in veterinary dermatology at the University of São Paulo (Brazil), with a sandwich period at the University of Minnesota, where she conducted research on the skin microbiome of cats. Since 2012, she has been an active member of the Brazilian Society of Veterinary Dermatology (SBDV). From 2015 to 2021, Dr. Santana served as the director of social media marketing, contributing to the organization's outreach and communication efforts.
